awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42139529-F016FF62-4BAC-4162-9624-96E0E38DABC2
Q42139529-F016FF62-4BAC-4162-9624-96E0E38DABC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42139529-F016FF62-4BAC-4162-9624-96E0E38DABC2
Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation.
P1476
Q42139529-F016FF62-4BAC-4162-9624-96E0E38DABC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42139529-F016FF62-4BAC-4162-9624-96E0E38DABC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ecd5b28e932f4d4614ec878a649e51d17a23c387
P1476
Therapeutic efficacy of SYM004
......
cetuximab and MET activation.
@en